| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/21/2011 | US20110177082 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/21/2011 | US20110177080 Novel p2x7 epitopes |
| 07/21/2011 | US20110177079 Cancer-testis antigens |
| 07/21/2011 | US20110177078 Immunogen and Antivenom Against Violin Spider Venom |
| 07/21/2011 | US20110177077 Pax 5 monoclonal antibody |
| 07/21/2011 | US20110177073 Recombinant production of mixtures of antibodies |
| 07/21/2011 | US20110177065 Methods of treating/preventing inflammation using combination of il-1 antagonist and il-18 binding protein |
| 07/21/2011 | US20110177058 Methods and compositions for modulating hgf/met |
| 07/21/2011 | US20110177057 Pharmaceutical preparation and manufacturing method thereof |
| 07/21/2011 | US20110177037 Solenopsis invicta Virus |
| 07/21/2011 | US20110177029 O-linked glycosylation using n-acetylglucosaminyl transferases |
| 07/21/2011 | US20110177022 Mammalian Cytokines; Related Reagents and Methods |
| 07/21/2011 | US20110177007 Dithienopyrrole Dyes for Imaging and Therapy |
| 07/21/2011 | US20110177006 Dithienofuran Dyes for Imaging and Therapy |
| 07/21/2011 | US20110177003 Proteins that fluoresce at infrared wavelengths or generate singlet oxygen upon illumination |
| 07/21/2011 | US20110177002 Cylic polyamines for binding phosphatidylserine |
| 07/21/2011 | US20110176996 Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof |
| 07/21/2011 | US20110174322 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes |
| 07/21/2011 | DE102010004541A1 Chimäre humane beta-Defensine Chimeric human beta-defensins |
| 07/21/2011 | CA2786936A1 Variants of group 5 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues |
| 07/21/2011 | CA2786935A1 Variants of group 6 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues |
| 07/21/2011 | CA2786847A1 Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (ibd) and irritable bowel syndrome (ibs) |
| 07/21/2011 | CA2786336A1 Bacterial host strain expressing recombinant dsbc and having reduced tsp activity |
| 07/21/2011 | CA2786335A1 Bacterial host strain comprising a mutant spr gene and having reduced tsp activity |
| 07/21/2011 | CA2785634A1 Process for the preparation of a biomass comprising plantaricin and uses thereof in medical field |
| 07/21/2011 | CA2785552A1 Insulin-like growth factor 1 receptor (igf-1r) protein srm/mrm assay |
| 07/21/2011 | CA2785534A1 Epidermal growth factor receptor (egfr) protein srm/mrm assay |
| 07/21/2011 | CA2785212A1 Novel bacillus thuringiensis gene with coleopteran activity |
| 07/21/2011 | CA2785185A1 Organic compounds for the regulation of vectorial ion channels |
| 07/21/2011 | CA2785136A1 Collagen fiber constructs for cruciate ligament replacement |
| 07/21/2011 | CA2785038A1 Bmp-7 variants with reduced immunogenicity |
| 07/21/2011 | CA2784671A1 Oxyntomodulin peptide analogue |
| 07/21/2011 | CA2784668A1 Oxyntomodulin peptide analogue |
| 07/20/2011 | EP2345746A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 07/20/2011 | EP2345735A1 Xanthomonas campestris with multiple copies of gumB and gumC |
| 07/20/2011 | EP2345732A1 Methods for intracellular delivery of nucleic acids |
| 07/20/2011 | EP2345731A1 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| 07/20/2011 | EP2345728A1 Yeast membrane protein expression system and its application in drug screening |
| 07/20/2011 | EP2345727A2 Fungal promoter for expressing a gene in a fungal cell |
| 07/20/2011 | EP2345726A2 Fungal promoter for expressing a gene in a fungal cell |
| 07/20/2011 | EP2345724A1 G-CSF analog compositions and methods |
| 07/20/2011 | EP2345722A1 Mutations in the parkin gene, compositions, methods and uses |
| 07/20/2011 | EP2345721A1 Recombinant gelatin in vaccines |
| 07/20/2011 | EP2345716A1 Recombinant influenza viruses for vaccines and gene therapy |
| 07/20/2011 | EP2345700A2 Polymer support bonded to agglomeration nuclei |
| 07/20/2011 | EP2345672A1 Anti-glycated cd59 antibodies and uses thereof |
| 07/20/2011 | EP2345670A1 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 07/20/2011 | EP2345669A1 NPC1L1 (NPC3) and methods of use thereof |
| 07/20/2011 | EP2345668A1 Sclerostin epitopes |
| 07/20/2011 | EP2345667A2 A method for producing an L-amino acid using a bacterium of the enterobacteriaceae family |
| 07/20/2011 | EP2345666A1 Carrier for targeting nerve cells |
| 07/20/2011 | EP2345665A2 Flavivirus NS1 subunit vaccine |
| 07/20/2011 | EP2345664A2 Replikin peptides and uses thereof |
| 07/20/2011 | EP2345424A1 CD4-specific antibody TRX1 and uses therefor |
| 07/20/2011 | EP2345420A1 Use of a TH1 immune response inducing adjuvant for enhancing immune responses |
| 07/20/2011 | EP2344891A2 Msp nanopores and related methods |
| 07/20/2011 | EP2344648A2 Recombinant vectors |
| 07/20/2011 | EP2344647A1 Hepatitis c virus expressing reporter tagged ns5a protein |
| 07/20/2011 | EP2344645A1 Rodent cancer model for human fgfr4 arg388 polymorphism |
| 07/20/2011 | EP2344636A2 Novel chimeric ligand-gated ion channels and methods of use thereof |
| 07/20/2011 | EP2344546A1 Single chain fc type iii interferons and methods of using same |
| 07/20/2011 | EP2344537A1 Bispecific anti-vegf/anti-ang-2 antibodies |
| 07/20/2011 | EP2344531A1 Modified variant bowman birk protease inhibitors |
| 07/20/2011 | EP2344530A1 Modulation of the activity and differentiation of cells expressing the osteoclast-associated receptor |
| 07/20/2011 | EP2344529A1 Novel octapeptide compounds derived from somatostatin and therapeutic use thereof |
| 07/20/2011 | EP2344528A1 Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof |
| 07/20/2011 | EP2344527A1 Materials and methods relating to stem cell mobilization by multi-pegylated granulocyte colony stimulating factor |
| 07/20/2011 | EP2344526A1 Neutrophil gelatinase-associated lipocalin (ngal) protein isoforms enriched from urine and recombinant chinese hamster ovary (cho) cells and related compositions, antibodies, and methods of enrichment, analysis and use |
| 07/20/2011 | EP2344525A1 Epitopes derived from satb2 and uses thereof |
| 07/20/2011 | EP2344524A2 Kit for the optimisation of protein synthesis/secretion |
| 07/20/2011 | EP2344523A1 Combination gas vaccines and therapeutics |
| 07/20/2011 | EP2344209A2 Cfhr1 as inhibitor of c5 convertase for the treatment of autoimmune diseases |
| 07/20/2011 | EP2344203A2 Method for the treatment of radiation-induced neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor (g-csf) variant |
| 07/20/2011 | EP2344200A2 Modified therapeutics peptides, methods of their preparation and use |
| 07/20/2011 | EP2344193A1 Rabies virus-based recombinant immunocontraceptive compositions and methods of use |
| 07/20/2011 | EP2344189A2 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens |
| 07/20/2011 | EP2344180A2 Methods for predicting production of activating signals by cross-linked binding proteins |
| 07/20/2011 | EP2142563B1 Bis-met histones |
| 07/20/2011 | EP2021799B1 Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease |
| 07/20/2011 | EP1833847B1 Igf-1 fusion polypeptides and therapeutic uses thereof |
| 07/20/2011 | EP1819354B1 Methods and compounds for treating diabetes |
| 07/20/2011 | EP1778724B9 Antiangiogenic peptides |
| 07/20/2011 | EP1692168B1 Single-chain insulin |
| 07/20/2011 | EP1625164B1 Method of detecting probnp with a monoclonal antibody binding to the amino acids 42-46 |
| 07/20/2011 | EP1496930B1 G-type peptides to ameliorate atherosclerosis |
| 07/20/2011 | EP1458748B1 Apoptotically active peptides |
| 07/20/2011 | EP1373477B1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 07/20/2011 | EP1214097B3 Nucleic acids encoding polyepitope polypeptides |
| 07/20/2011 | EP1181317B1 An integrin heterodimer and an alpha subunit thereof |
| 07/20/2011 | CN1993469B Recombinant alpha-fetoprotein, method and means for preparation thereof, compositions on the base thereof and use thereof |
| 07/20/2011 | CN1951965B Glp-1衍生物 Glp-1 derivatives |
| 07/20/2011 | CN102131934A Plants having enhanced yield-related traits and method for making same |
| 07/20/2011 | CN102131920A Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof |
| 07/20/2011 | CN102131919A Method for proliferation of pluripotent stem cell |
| 07/20/2011 | CN102131830A Chimeric respiratory syncytial virus polypeptide antigens |
| 07/20/2011 | CN102131826A Crystal structure of human sortilin and use of identifying ligands of sortilin, thereof |
| 07/20/2011 | CN102131825A N-glycosylated human growth hormone with prolonged circulatory half-life |
| 07/20/2011 | CN102131824A Plants with altered root architecture, related constructs and methods involving genes encoding rep2 polypeptides and homologs thereof |
| 07/20/2011 | CN102131823A Clostridial neurotoxins with altered persistency |
| 07/20/2011 | CN102131822A Methods for dosing activin-actriia antagonist and monitoring of treated patients |